StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co (BMY) stock

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3031% below fair value
$63.43+1.11 (+1.78%)

Close on Nov 13, 2026Market cap $129.66BP/E 14.1Yield 3.93%

Bristol Myers Squibb statistics

105 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 4, 2027 (estimated, before the open)
Last ex-dividend date
Oct 2, 2026
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$129.66B
$275.32M
Enterprise Value
$159.95B
$144.91M
PE Ratio
14.06
25.11
PS Ratio
2.59
3.66
PB Ratio
5.54
2.01
P/FCF Ratio
13.96
17.86
P/OCF Ratio
12.17
12.99

Enterprise valuationIndustry

EV / Sales
3.20
2.57
EV / EBITDA
10.14
16.50
EV / FCF
17.23
22.27

Share statisticsIndustry

Shares Change (YoY)
0.49%
10.8%
Float
2.04B
49M
Shares Held by Insiders
0.06%
11.6%
Shares Held by Institutions
81.9%
56.4%

Short sellingIndustry

Short Interest
47M
–
Short Interest Change
-6.20%
-0.80%
Short % of Float
2.29%
8.98%
Short % of Shares Outstanding
2.29%
6.30%
Days to Cover
4.24
5.16

Stock price statisticsIndustry

52-Week High
$68.64
–
52-Week Low
$45.27
–
20-Day Moving Average
$62.08
–
50-Day Moving Average
$61.90
–
200-Day Moving Average
$60.34
–
Average True Range (14)
$1.76
–
Price Change (1 Week)
2.08%
-1.15%
Price Change (1 Month)
4.72%
-4.86%
Price Change (3 Months)
-1.86%
-21.1%
Price Change (6 Months)
11.3%
-20.7%
Price Change (YTD)
17.6%
-23.6%
Price Change (1 Year)
29.2%
-22.7%
Price Change (3 Years)
25.6%
-29.5%
Price Change (5 Years)
6.73%
-77.8%
Price Change (10 Years)
12.1%
-65.4%
Average Volume (10 Days)
9M
–
Average Volume (20 Days)
10M
–
Average Volume (90 Days)
11M
–
Relative Volume
0.82
0.70
Relative Strength Index (14)
55.8
43.4
Volatility (1 Year)
27.8%
80.1%
Beta (5 Years)
0.25
1.07

MarginsIndustry

Gross Margin
69.2%
53.1%
Pretax Margin
22.6%
-11.6%
Profit Margin
18.5%
-31.6%
EBITDA Margin
31.5%
-27.7%
FCF Margin
18.6%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
44.1%
-50.3%
Return on Assets (ROA)
9.96%
-40.6%

Financial positionIndustry

Current Ratio
1.59
3.30
Quick Ratio
1.16
2.39
Debt / Equity
1.83
0.49
Debt / EBITDA
2.72
3.15
Debt / FCF
4.62
4.65
Net Debt / EBITDA
1.92
1.97

GrowthIndustry

Revenue Growth (YoY)
4.16%
6.82%
Net Income Growth (YoY)
53.1%
-14.4%
EPS Growth (YoY)
52.4%
-12.3%
FCF Growth (YoY)
-39.3%
6.85%
Revenue Growth (3Y CAGR)
1.45%
2.25%
Revenue Growth (5Y CAGR)
2.54%
6.41%
EPS Growth (3Y CAGR)
5.46%
1.30%

EfficiencyIndustry

Asset Turnover
0.54
0.40
Inventory Turnover
5.64
2.73
Revenue Per Employee
$1.54M
$429.29K
Profits Per Employee
$284.40K
-$690.06K
Employee Count
32,500
75
WACC
6.75%
10.2%

Income statement (TTM)Industry

Revenue
$50.03B
$66.37M
Gross Profit
$34.64B
$120.78M
Pretax Income
$11.33B
-$12.98M
Net Income
$9.24B
-$22.39M
EBITDA
$15.78B
-$17.04M
EPS (Diluted)
$4.51
-$0.76

Balance sheetIndustry

Total Debt
$42.88B
$116.91M
Net Cash (Debt)
-$30.30B
$17.80M
Net Cash Per Share
-$14.82
$0.80
Equity (Book Value)
$23.40B
$53.27M
Book Value Per Share
$11.45
$1.50
Tangible Book Value
-$15.27B
$26.82M
Working Capital
$11.01B
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
$10.65B
-$12.35M
Capital Expenditures
-$1.37B
-$1.00M
Free Cash Flow
$9.29B
-$18.21M
FCF Per Share
$4.54
-$0.42

Dividends and yieldsIndustry

Earnings Yield
7.13%
-22.0%
FCF Yield
7.16%
-9.44%
Dividend Yield
3.93%
1.88%
Shareholder Yield
3.93%
0.00%
Dividend Per Share
$2.49
$0.83
Dividend Growth (YoY)
2.89%
2.37%
Years of Dividend Growth
18
0
Payout Ratio
55.4%
55.4%
FCF Payout Ratio
55.1%
43.7%

Taxes and interestIndustry

Interest Expense
$1.65B
$2.93M
Income Tax
$2.09B
$73.00K
Effective Tax Rate
18.4%
20.7%

Scores and fair valueIndustry

Graham Number
$34.09
$19.34
Graham Upside
-46.3%
-46.6%
Altman Z-Score
2.24
0.23
Piotroski F-Score
8
4
Beneish M-Score
-2.68
-2.63
Lynch Fair Value
$24.62
–
Lynch Upside
-61.2%
-28.9%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodBMYS&P 500DifferenceBMY per yearS&P 500 per year
1 month+11.9%-3.0%+15.0 pts
3 months-0.9%-2.8%+1.9 pts
Year to date+22.8%+11.5%+11.3 pts
1 year+36.2%+13.5%+22.8 pts
3 years+45.7%+77.7%−32.0 pts+13.4%+21.1%
5 years+31.3%+72.6%−41.3 pts+5.6%+11.5%
10 years+60.6%+308.2%−247.6 pts+4.9%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

47M BMY shares were sold short on Oct 30, 2026, down 6.2% from the previous report, or 2.29% of the shares available to trade. At recent volumes it would take 4.2 days to buy them back. Over the last 20 sessions, 46.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202646,849,171-6.2%11,059,3664.2
Oct 15, 202649,948,083+8.9%13,689,4263.6
Sep 30, 202645,847,626+9.2%15,248,5393.0
Sep 15, 202641,969,577-4.8%7,235,9315.8
Aug 31, 202644,073,318-3.9%8,368,8265.3
Aug 14, 202645,852,662-12.4%13,183,2813.5
Jul 31, 202652,336,079+16.5%11,294,1214.6
Jul 15, 202644,935,362+10.9%10,603,4784.2
Jun 30, 202640,531,289+2.4%16,383,2352.5
Jun 15, 202639,595,308+2.8%11,894,7363.3
May 29, 202638,507,952+4.9%11,144,3613.5
May 15, 202636,716,099+17.2%10,381,7003.5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?